Medina ALG, Pérez RDO, Ramos RG, López VF

Language: Spanish
References: 29
Page: 111-114
PDF size: 166.11 Kb.

ABSTRACT

Chloroquine-induced hyperpigmentation is a well-known side effect of this drug, it affects skin and mucous a few months after initiating treatment. This side effect has been described rarely with hydroxychloroquine, with only a few case reports. We present a 58-year-old female with systemic lupus erythematosus and mucocutaneous hyperpigmentation induced by hydroxychloroquine.

REFERENCES

1. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P et al., Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review, Ann Rheum Dis 2010; 69:20-8.

2. Ochsendorf F, Use of antimalarials in dermatology, J Dtsch Dermatol Ges 2010; 8:829-45.

3. Tenenbaum L y Tuffanelli D, Antimalarial agents. Chloroquine, hydroxychloroquine, and quinaquine, Arch Dermatol 1980; 116:587-91.

4. Hendrix J y Greer K, Cutaneous hyperpigmentation caused by systemic drugs, Int J Dermatol 1992; 31:458-66.

5. Dereure O, Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment, Am J Clin Dermatol 2001; 2:253-62.

6. Melikoglu MA, Melikoglu M, Gurbuz U et al., Hydroxychloroquine-induced hyperpigmentation: a case report, J Clin Pharm Ther 2008; 33:699-701.

7. Kasper R, Flueckinger B, Gobbi S et al., Hydroxychloroquine-induced hyperpigmentation, J Dtsch Dermatol Ges 2014; 12(2):158-61.

8. Jallouli M, Frances C, Piette J et al., Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematous: a case-control study, jama Dermatol 2013; 149: 935-40.

9. Skare T, Ribeiro C, Souza F et al., Antimalarial cutaneous side effects: a study in 209 users, Cutan Ocul Toxicol 2011; 30:45-9.

10. Mir A, Booyd K, Meehan S et al., Hydroxycholoroquine-induced hyperpigmentation, Dermatol Online J 2013; 19(12):20723.

11. Kalampalikis A, Goetze S y Elsner P, Isolated hyperpigmentation of the oral mucosa due to hydroxychloroquine, J Dtsch Dermatol Ges 2012; 10:921-2.

12. Veraldi S, Schianchi-Veraldi R y Scarabelli G, Pigmentation of the gums following hydroxychloroquine therapy, Cutis 1992; 49:281-2.

13. True D, Bryant L, Harris M et al., Clinical images: hydroxychloroquine associated mucocutaneous hyperpigmentation, Arthritis Rheum 2002; 46(6):1698.

14. Millard T, Kirk A y Ratnavel R, Cutaneous hyperpigmentation during therapy with hydroxychloroquine, Clin Exp Dermatol 2004; 29(1):92-3.

15. Reynaert S, Setterfield J y Black M, Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus, J Eur Acad Dermatol Venerol 2006; 20(4):487-8.

16. Amichai B, Gat A y Grunwald M, Cutaneous hyperpigmentation during therapy with hydroxychloroquine, J Clin Rheumatol 2007; 13:113.

17. Rood MJ, Vermeer MH y Huizinga TW, Hyperpigmentation of the skin due to hydroxychloroquine, Scand J Rheumatol 2008; 37:158.

18. Puri PK, Lountzis NI, Tyler W et al., Hydroxychloroquine induced hyperpigmentation: the staining pattern, J Cutan Pathol 2008; 35: 1134-7.

19. Morrison L, Nordlund J y Heffernan M, Persistent cutaneous hyperpigmentation duo to hydroxychloroquinone one year after therapy discontinuation, Dermatol Online J 2009; 15(12):15.

20. Kalabalikis D, Patsatsi A, Trakatelli MG et al., Hyperpigmented forearms and nail: a quiz, Acta Derm Venereol 2010; 90:657-9.

21. Cho E, Kim B, Park E et al., Hydroxychloroquine induced hyperpigmentation, J Dermatol 2012; 39:859-60.

22. Jallouli M, Leroux G, Halabi-Tawil M et al., Skin pigmentation in a patient with systemic lupus erytematosus, Rev Med Interne 2010; 31(8):566-7.

23. Lisi P, Assalve D y Hansel K, Phototoxic and photoallergic dermatitis caused by hydroxychloroquine, Contact Dermatitis 2004; 50:255-6.

24. Lerman M, Karimbux N, Guze K et al., Pigmentation of the hard palate, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107:8-12.

25. Savage N, Barber M y Adakins K, Pigmentary changes in rat oral mucosa following antimalarial therapy, J Oral Pathol 1986; 15:468-71.

26. Lippard V y Kauer G, Pigmentation of the palate and subungual tissues associated with suppressive quinacrine hydrochloride therapy, Am J Trop Med Hyg 1945; 25:469-71.

27. Kleinegger C, Hammond H y Finkelstein M, Oral mucosal hyperpigmentation secondary to antimalarial drug therapy, Oral Surg Oral Med Oral Pathol Oral Rdiol Endod 2000; 90:189-94.

28. Mattsson U, Halbritter S, Mörner S et al., Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111: 12-6.

29. Tracy C, Blakey B, Parker G et al., Hydroxychloroquine-induced hyperpigmentation, J Clin Rheumatol 2013; 19:292.